Cargando…
Cardiac tamponade and adrenal insufficiency due to pembrolizumab: a case report
INTRODUCTION: Patients who receive or have received anti-programmed cell-death-1 (PD-1) monoclonal antibodies can develop immune-related adverse events due to activation of the immune system. CASE PRESENTATION: We report a case of a patient who received pembrolizumab and presented with cardiac tampo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177032/ https://www.ncbi.nlm.nih.gov/pubmed/31020118 http://dx.doi.org/10.1093/ehjcr/yty038 |